By RYAN ALLWAY December 13th, 2016 Source: SECFilings.com Cell MedX Corp. (OTCQB: CMXC), a development-stage biotech company focused on harnessing the power of microcurrent technologies to address numerous health conditions, recently expanded the potential addressable market for its eBalance Pro…
By RYAN ALLWAY November 29, 2016 Source: SECFilings.com Microcurrent therapy uses extremely low-level electrical currents that promote general wellness and alleviate complications associated with certain medical conditions. On a cellular level, the technology stimulates a dramatic increase in ATP (adenosine…
Originally Published Sept 30, 2015: Keeping A Close Eye On Advances In Diabetes Treatments – Steven Bulwa | Seeking Alpha Addressing the diabetes epidemic from a different angle Reducing healthcare and societal costs by improving the overall health of diabetics…
Published: 9 Sep, 2015 — RT USA Half of all US adults currently have diabetes or pre-diabetes, a new study revealed. The new research shows that the disease has made gains across every racial and ethnic group in the last 18…
First Published Sep 8 2015 Maggie Fox – NBC News <link href=”http://nodeassets.nbcnews.com/styles/658e3d49.fonts.css” rel=”stylesheet”> <link href=”http://netdna.bootstrapcdn.com/font-awesome/4.0.3/css/font-awesome.min.css” rel=”stylesheet”> <style type=”text/css”> html body .no-js-show{ display: block !important;} html body .no-js-hide{ display: none !important;} </style> Half of all U.S. adults have diabetes or blood…
REDONDO BEACH, CA / ACCESSWIRE / July 21, 2015 / Diabetes affects approximately 387 million people worldwide and that figure is expected to soar to nearly 600 million by 2035, according to the International Diabetes Federation. At the same time,…
WHITEFISH, MT / ACCESSWIRE / June 29, 2015 / Small-cap biotech stocks have been top performers so far this year, with the PowerShares S&P SmallCap Healthcare ETF (PSCH) returning 25%, which is 5x better than the SPDR S&P 500 ETF’s…